Signal active
Bio
Nick is a synthetic chemist and molecular biologist who has completed a PhD in Chemistry and postdoctoral fellowship in Developmental Biology at Stanford University. Nick was a Beckman Fellow, a National Science Foundation Graduate Research Fellow, a Lieberman Fellow, a Stanford Molecular Imaging Scholars Fellow, and a Younger Fellow. He has eighteen peer-reviewed publications on topics including palladium catalysis, super-resolution fluorescence imaging, single-molecule DNA detection, and cancer biology, and he holds two US patents. Nick is currently a Research Staff Member at HGST, a Western Digital Company. He founded his first company, Conley Chemical Consulting, in graduate school, and has gone on to found a successful cosmetics company and a dental technology company. He recently licensed a patent for a dental appliance cleansing formula to a major consumer packaged goods company; the product is currently sold nationwide in major retailers.
Location
San Francisco, California, United States, North America
Social
Primary Organization
2015
51-100
Biotechnology, Biopharma, Therapeutics
Jobs history
3
Locus Biosciences
Vice President of Technology, Pharmaceutical Operations and Technology
2021 - Current
Advisor
2021 - Invalid date
Locus Biosciences
Senior Director, CMC
2020 - 2021
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Nick Conley is the Vice President of Technology, Pharmaceutical Operations and Technology at Locus Biosciences, based in United States, North America. With a background in Biotechnology, Nick Conley has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
Miron Cuperman
No designation
Alex Pesch
No designation
Gordon Eubanks
Director
Joseph Goodman
No designation
Investment portfolio
2
0
Personal investment
2
Annouced Date | Organization Name | Funding Round | Money Raised |
---|---|---|---|
Jan 14, 2014 | Ligandal | Convertible Note - Ligandal | 64.0K |
Nov 01, 2016 | Exnodes | Seed Round - Exnodes | 2.0M |
Partner investment
0
There is no partner investment available on this profile
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity
There is no recent news or activity for this profile.